With the provisions of HB 1389, there will be significant changes to health insurance policies in terms of breast cancer screening requirements. By mandating coverage for low-dose mammography screenings and associated diagnostic examinations, the bill aims to promote early detection of breast cancer, which is crucial for effective treatment and increased survival rates. Additionally, it eliminates financial barriers for women seeking these vital health services, which could lead to greater compliance with screening recommendations and overall improved public health outcomes.
Summary
House Bill 1389 focuses on enhancing coverage for low-dose mammography screening and expanding the types of diagnostic examinations included under health benefit plans. The bill amends existing regulations to ensure specific breast cancer screenings and diagnostic tests, such as breast magnetic resonance imaging, breast ultrasounds, and molecular breast imaging, are covered. Furthermore, it aims to standardize the rights of women aged 35 and older regarding mammographic screenings, granting them the right to screenings at specified intervals without being subjected to additional costs like deductibles or co-payments.
Sentiment
The sentiment surrounding HB 1389 appears to be largely positive, reflecting an understanding of the importance of preventative healthcare measures. Supporters of the bill, including healthcare advocates and women’s health organizations, view it as a progressive step toward ensuring comprehensive health coverage for breast cancer screening. The provision to eliminate co-payments and deductibles is particularly championed as a means to foster equitable access to necessary health services.
Contention
While the bill has garnered significant support, there may be some contention among insurance providers concerned about the financial implications of mandated coverage for additional diagnostic procedures. Critics might argue about the potential strain on healthcare costs and the insurance market. Furthermore, discussions may arise around the efficacy and necessity of some of the newer diagnostic technologies included in the coverage mandate. Balancing improved healthcare access with economic feasibility and insurance sustainability will likely be key points of debate as the bill moves forward.
Schools; Student Retention Protocol Act of 2025; definitions; screenings, assessments, and evaluations for students; availability of funding; effective date; emergency.
Landlord and tenant; requiring criminal history screening policy for award of certain tax credit; establishing procedures for certain screening policies. Effective date.
Schools; hearing screening; notification; State Board of Health; rules; statewide registry; hearing examination; written report; school districts; State Board of Education; annual report; effective date.
Health: testing; notification of dense breast tissue; eliminate, and provide for other general amendments to the use of radiation machines. Amends secs. 13501, 13521, 13522 & 13523 of 1978 PA 368 (MCL 333.13501 et seq.) & repeals secs. 13524 & 13531 of 1978 PA 368 (MCL 333.13524 & 333.13531).
To Increase Accessibility While Ensuring Quality For Certain Facilities Performing Mammography Services; And To Amend The Law Concerning The Quality Standards For Accreditation Of Facilities For Mammography.